Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
about
Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Treatment Duration, Healthcare ...... Retrospective Claims Analysis
@en
Treatment Duration, Healthcare ...... Retrospective Claims Analysis
@nl
type
label
Treatment Duration, Healthcare ...... Retrospective Claims Analysis
@en
Treatment Duration, Healthcare ...... Retrospective Claims Analysis
@nl
prefLabel
Treatment Duration, Healthcare ...... Retrospective Claims Analysis
@en
Treatment Duration, Healthcare ...... Retrospective Claims Analysis
@nl
P2093
P2860
P1433
P1476
Treatment Duration, Healthcare ...... Retrospective Claims Analysis
@en
P2093
Bruce A Brown
Hongbo Yang
Neil M Schultz
Samuel Wilson
Scott C Flanders
Stanislav Lechpammer
Vahan Kassabian
P2860
P2888
P304
P356
10.1007/S12325-018-0774-1
P407
P577
2018-10-01T00:00:00Z